Pre-Filled Syringes and Injectable Drug Devices Virtual Conference: Online Access Only

Memo

The pre-filled syringes industry is growing at an exponential rate with innovations in parenteral delivery device development to aid self-administration and deliver biologics, high concentration, and large-volume drug products. This year's conference will explore the exciting advances in the combination product delivery space including insights into how the industry is adapting to the delayed EU MDR, takeaways from the global pandemic and a future outlook exploring how pharma, device developers and regulators can work together to encourage innovation. Part of the leading injectables series of events, SMi's 14th annual conference will bring you the key insights you need to grow and enhance your pre-filled syringes portfolio and discover what the future holds for the PFS and combination products industry. Virtual Conference: Online Access Only Topics of discussion will include the latest updates on the EU MDR, Article 117 and UK regulatory guidance from the MHRA, insights into the evolving digital health landscape for connected delivery devices, containment considerations for novel delivery, patient centric approaches to device design and much more... The two-day agenda offers you peer-to-peer networking with Global Product Managers, Senior PFS Engineers, Device Testing Managers, Heads of Late-Stage PFS Development and many more. As Europe's first Pre-Filled Syringes Conference of 2022, this event is not to be missed. We look forward to welcoming you to the conference in January. BENEFITS OF ATTENDING: - Engage with industry leaders on the key takeaways from the pandemic and how this can be applied to future accelerated development- Explore updates to drug device combination product design approaches putting the user first with industry case studies from big pharma- Assess the current landscape of device delivery mechanisms and how industry can work together to promote innovation- Understand the landscape of delivery for novel drug products, fragile molecules and long acting injectables in the interactive panel discussion View the full agenda and speaker line-up online: www.pre-filled-syringes.com/evvntwl EARLY-BIRD RATES: - BOOK BY 30TH SEPTEMBER AND SAVE £400 - BOOK BY 29TH OCTOBER AND SAVE £200- BOOK BY 30TH NOVEMBER AND SAVE £100 Registrations can be made on the event website at: www.pre-filled-syringes.com/evvntwl Virtual Conference: Online Access Only Chairs for 2022: - Bjørg Kaae Hunter, Department Manager, RA CMC and Device; RA NextGen Drug-Device, Novo Nordisk- Daniel Latham, Head Connected Health Product Development, Novartis Featured speakers: - David Braun, Head of Connected Health and Medical Devices Business Solutions, Merck Group- Louise Place, Director, Devices, GSK- Jochen Zenker, Head of Laboratory Process Engineering, Device Development, Boehringer Ingelheim- Joel Richard, Chief Development Officer, MedinCell- Sachin Dubey, Head of Drug Product and Analytical Development, Ichnos Sciences- Raphael Nudelman, Director of Chemical and Computational Toxicology, Teva Pharmaceuticals- Richard Simcock, Human Factors Scientist, CPD, Teva- Michael Becker, Packaging Engineer, Launch + Transfer Operations, Boehringer Ingelheim Pharma GmbH and Co. KG- Arabe Ahmed, Medicinal Technical Expert, BSI Virtual Conference: Online Access Only Tickets: https://go.evvnt.com/880261-0?pid=5569 Date and Time: On Wed, Jan 12, 22 ( 9:00 AM) - Thu, Jan 13, 22 ( 5:30 PM) Prices:General Admission: GBP 1499.00,Early bird - Book by 30 September 2021: GBP 1099.00,Early bird - Book by 29 October 2021: GBP 1299.00,Early bird - Book by 30 November 2021: GBP 1399.00